The trial, believed to be the first of its kind, was small, and the effect was far from dramatic.
At one point at the beginning of the pandemic, there was hope that a popular and inexpensive over-the-counter heartburn drug might hold promise for treating Covid-19, but a newly published study shows mixed results.
In the clinical trial, people with mild to moderate Covid-19 who took very high doses of famotidine, the active ingredient in Pepcid, had some improvement in their symptoms more quickly than those who took a placebo, a pill that does nothing. But the trial, believed to be the first of its kind, was small, and the effect was far from dramatic. Among the 55 study participants, those who were assigned to take famotidine had an estimated 50% reduction in symptoms at 8.
Dr. Paul Offit pointed to findings in the new study that examined inflammation markers in the blood of 35 of the participants. Those results showed that the people on famotidine had their inflammation resolve more quickly than those on placebo. The NIH recommends using tocilizumab, an arthritis anti-inflammatory drug, to treat hospitalized Covid patients.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
NJ’s COVID-19 prison release program restarts Thursday with 260 freed earlyNew Jersey’s pandemic-related early release program will officially resume Thursday with the freeing of another 260 individuals.
Baca lebih lajut »
Covid-19 news: NHS backlog could grow by millions over next two yearsToday’s covid-19 news: · NHS backlog could grow by millions over next two years · New York and other US states ditch mask mandates · EU pushes for wet markets ban and rewards for virus detecting countries
Baca lebih lajut »
COVID-19 truck blockade starting to have wider effects outside CanadaThe protest by people mostly in pickup trucks entered its third day at the Ambassador Bridge between Detroit and Windsor, Ontario.
Baca lebih lajut »
Alaska court system faces significant trial backlog as courtrooms reopen from COVID-19 closuresChief justice asks for $1.8 million in supplemental funding during annual State of the Judiciary address.
Baca lebih lajut »
Covid-19 news: England may scrap all restrictions in two weeksThe latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Baca lebih lajut »